Report Detail

Pharma & Healthcare Global Intravenous Immunoglobulin (IVIg) Market Insights, Forecast to 2025

  • RnM2459682
  • |
  • 15 March, 2019
  • |
  • Global
  • |
  • 114 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Intravenous Immunoglobulin (IVIg) Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Intravenous Immunoglobulin (IVIg) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Product
      • 1.4.2 IVIg Liquid
      • 1.4.3 IVIg Powder
    • 1.5 Market by End User
      • 1.5.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by End User
      • 1.5.2 Immunodeficiency
      • 1.5.3 Autoimmune Disease
      • 1.5.4 Acute Infection
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Intravenous Immunoglobulin (IVIg) Market Size
      • 2.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2014-2025
      • 2.1.2 Global Intravenous Immunoglobulin (IVIg) Sales 2014-2025
    • 2.2 Intravenous Immunoglobulin (IVIg) Growth Rate by Regions
      • 2.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Regions
      • 2.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Intravenous Immunoglobulin (IVIg) Sales by Manufacturers
      • 3.1.1 Intravenous Immunoglobulin (IVIg) Sales by Manufacturers
      • 3.1.2 Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers
      • 3.1.3 Global Intravenous Immunoglobulin (IVIg) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers
      • 3.2.1 Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Intravenous Immunoglobulin (IVIg) Price by Manufacturers
    • 3.4 Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution, Product Types
      • 3.4.1 Intravenous Immunoglobulin (IVIg) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Product
    • 4.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Product
    • 4.3 Intravenous Immunoglobulin (IVIg) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Intravenous Immunoglobulin (IVIg) Breakdown Data by End User

    6 North America

    • 6.1 North America Intravenous Immunoglobulin (IVIg) by Countries
      • 6.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Countries
      • 6.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Intravenous Immunoglobulin (IVIg) by Product
    • 6.3 North America Intravenous Immunoglobulin (IVIg) by End User

    7 Europe

    • 7.1 Europe Intravenous Immunoglobulin (IVIg) by Countries
      • 7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Countries
      • 7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Intravenous Immunoglobulin (IVIg) by Product
    • 7.3 Europe Intravenous Immunoglobulin (IVIg) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Intravenous Immunoglobulin (IVIg) by Countries
      • 8.1.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Countries
      • 8.1.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Intravenous Immunoglobulin (IVIg) by Product
    • 8.3 Asia Pacific Intravenous Immunoglobulin (IVIg) by End User

    9 Central & South America

    • 9.1 Central & South America Intravenous Immunoglobulin (IVIg) by Countries
      • 9.1.1 Central & South America Intravenous Immunoglobulin (IVIg) Sales by Countries
      • 9.1.2 Central & South America Intravenous Immunoglobulin (IVIg) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Intravenous Immunoglobulin (IVIg) by Product
    • 9.3 Central & South America Intravenous Immunoglobulin (IVIg) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) by Countries
      • 10.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Countries
      • 10.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) by Product
    • 10.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) by End User

    11 Company Profiles

    • 11.1 Baxter
      • 11.1.1 Baxter Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Baxter Intravenous Immunoglobulin (IVIg) Products Offered
      • 11.1.5 Baxter Recent Development
    • 11.2 Grifols
      • 11.2.1 Grifols Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Grifols Intravenous Immunoglobulin (IVIg) Products Offered
      • 11.2.5 Grifols Recent Development
    • 11.3 CSL
      • 11.3.1 CSL Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 CSL Intravenous Immunoglobulin (IVIg) Products Offered
      • 11.3.5 CSL Recent Development
    • 11.4 Octapharma
      • 11.4.1 Octapharma Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Products Offered
      • 11.4.5 Octapharma Recent Development
    • 11.5 Biotest
      • 11.5.1 Biotest Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Biotest Intravenous Immunoglobulin (IVIg) Products Offered
      • 11.5.5 Biotest Recent Development
    • 11.6 Kedrion
      • 11.6.1 Kedrion Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Products Offered
      • 11.6.5 Kedrion Recent Development
    • 11.7 Hualan Bio
      • 11.7.1 Hualan Bio Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Products Offered
      • 11.7.5 Hualan Bio Recent Development
    • 11.8 CNBG
      • 11.8.1 CNBG Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 CNBG Intravenous Immunoglobulin (IVIg) Products Offered
      • 11.8.5 CNBG Recent Development
    • 11.9 Shanghai RAAS
      • 11.9.1 Shanghai RAAS Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products Offered
      • 11.9.5 Shanghai RAAS Recent Development
    • 11.10 CBPO
      • 11.10.1 CBPO Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 CBPO Intravenous Immunoglobulin (IVIg) Products Offered
      • 11.10.5 CBPO Recent Development
    • 11.11 LFB Group
    • 11.12 BPL
    • 11.13 Sichuan Yuanda Shuyang

    12 Future Forecast

    • 12.1 Intravenous Immunoglobulin (IVIg) Market Forecast by Regions
      • 12.1.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Regions 2019-2025
    • 12.2 Intravenous Immunoglobulin (IVIg) Market Forecast by Product
      • 12.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Product 2019-2025
    • 12.3 Intravenous Immunoglobulin (IVIg) Market Forecast by End User
    • 12.4 North America Intravenous Immunoglobulin (IVIg) Forecast
    • 12.5 Europe Intravenous Immunoglobulin (IVIg) Forecast
    • 12.6 Asia Pacific Intravenous Immunoglobulin (IVIg) Forecast
    • 12.7 Central & South America Intravenous Immunoglobulin (IVIg) Forecast
    • 12.8 Middle East and Africa Intravenous Immunoglobulin (IVIg) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Intravenous Immunoglobulin (IVIg) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
      North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), enjoying production market share nearly 23% in 2016.
      North America is the largest sales place, with a sales market share nearly 44% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 22%.
      Market competition is intense. Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
      The global Intravenous Immunoglobulin (IVIg) market is valued at 8120 million US$ in 2018 and will reach 12800 million US$ by the end of 2025, growing at a CAGR of 5.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravenous Immunoglobulin (IVIg) market based on company, product type, end user and key regions.

      This report studies the global market size of Intravenous Immunoglobulin (IVIg) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous Immunoglobulin (IVIg) in these regions.
      This research report categorizes the global Intravenous Immunoglobulin (IVIg) market by top players/brands, region, type and end user. This report also studies the global Intravenous Immunoglobulin (IVIg) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Baxter
      Grifols
      CSL
      Octapharma
      Biotest
      Kedrion
      Hualan Bio
      CNBG
      Shanghai RAAS
      CBPO
      LFB Group
      BPL
      Sichuan Yuanda Shuyang

      Market size by Product
      IVIg Liquid
      IVIg Powder
      Market size by End User
      Immunodeficiency
      Autoimmune Disease
      Acute Infection

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Intravenous Immunoglobulin (IVIg) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Intravenous Immunoglobulin (IVIg) market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Intravenous Immunoglobulin (IVIg) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Intravenous Immunoglobulin (IVIg) submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Intravenous Immunoglobulin (IVIg) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Bottle). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravenous Immunoglobulin (IVIg) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Intravenous Immunoglobulin (IVIg) . Industry analysis & Market Report on Intravenous Immunoglobulin (IVIg) is a syndicated market report, published as Global Intravenous Immunoglobulin (IVIg) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Intravenous Immunoglobulin (IVIg) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,065.00
      4,597.50
      6,130.00
      3,494.44
      5,241.66
      6,988.89
      430,080.30
      645,120.45
      860,160.60
      271,964.55
      407,946.83
      543,929.10
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report